ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2593

A Long-term Synovial Tissue 3D Model Incorporating Fibroblasts, Macrophages, Endothelial Cells, and Other Immune Cells Such as Innate Lymphoid Cells Enables Animal Model-Independent Rheumatoid Arthritis Research

Miriam Bollmann1, Oskar Landberg2, Negar Ayoubzadeh2, Charlotte A. Jonsson2, Inger Gjertsson2 and Mattias Svensson2, 1University of Gothenburg, Göteborg, Sweden, 2University of Gothenburg, Gothenburg, Sweden

Meeting: ACR Convergence 2024

Keywords: Fibroblasts, Synovial, Inflammation, macrophages, rheumatoid arthritis, Structure

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Abstracts: Cytokines & Cell Trafficking

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory joint disease with multiple tissues contributing to its pathology, including the synovial membrane. The RA synovial membrane consists of various cell types, including fibroblast-like synoviocytes (FLS), macrophages (Mϕ), endothelial cells (EC), and immune cells. Interactions among these cells drive the inflammatory processes and local joint destruction, characteristics of RA. Traditional 2D cell culture is insufficient for modeling this complex cellular environment and its dynamic interactions. Thus, advanced 3D culture models that incorporate the diverse cell types are needed, as this would offer a more physiologically relevant platform for studying RA synovial pathophysiology and testing therapeutic interventions.

Methods: We assessed two different 3D culture systems, a Matrigel-based and a hanging drop system. For Matrigel 3D cultures, FLS alone or in combination with Mϕ, EC (HUVEC), and/or group 2 innate lymphoid cells (ILC2) were resuspended in Matrigel and plated into poly-HEMA-coated plates. For the hanging drop system, cells (as described above) were resuspended in FLS media, pipetted into poly-HEMA-precoated 96-well plates, which were then turned upside down and left untouched for one week. Media was changed every three days, with stimulation (TNFα 20 ng/ml) added after one week for both systems. 3D cultures were harvested after a total of three weeks and evaluated by H&E, immunofluorescence (IF) staining, and expression of mRNA by qPCR.

Results: We successfully developed a 3D Matrigel-based culture system that can incorporate FLS, Mϕ, EC, and ILC2. The 3D cultures mimicked physiological properties of the synovial membrane, forming a defined lining layer, as well as expressing specific FLS markers such as Podoplanin (PDPN) and CD55. IF staining revealed that the inclusion of Mϕ increased the basal expression of PDPN (0.006±0.010 vs 0.150±0.069, p=0.022, n=3), a marker for aggressive RA FLS. TNFα stimulation further increased FLS expression of both PDPN (0.150±0.069 vs 3.778±0.665, p< 0.0001, n=3) and CD55 (0.017±0.005 vs 0.592±0.619, p=0.020, n=3). Further, IL6 mRNA expression was significantly upregulated upon TNFα stimulation (p=0.001, n=3) and interestingly, 3D cultures with RA FLS showed increased IL6 mRNA expression compared to those with healthy FLS. To avoid non-physiological matrix components and growth factors present in Matrigel, a multicellular, long-term 3D model using the hanging drop system was developed. In this system, we found FLS to produce their own extracellular matrix, including the human synovial components collagen types I and IV. In addition, hanging drop cultures showed similar synovial characteristics, including CD55 and PDPN expression.

Conclusion: Here, we present two long-term 3D culture systems that incorporate synovial membrane-specific cells, including FLS, Mϕ, EC, and ILC2. Our model exhibits synovia-specific cellular architecture and RA-specific inflammatory responses, providing an excellent platform for testing novel therapeutic compounds over an extended period and studying specific signaling pathways and cell-cell interactions in a physiological manner independent of mouse models.


Disclosures: M. Bollmann: None; O. Landberg: None; N. Ayoubzadeh: None; C. Jonsson: None; I. Gjertsson: None; M. Svensson: None.

To cite this abstract in AMA style:

Bollmann M, Landberg O, Ayoubzadeh N, Jonsson C, Gjertsson I, Svensson M. A Long-term Synovial Tissue 3D Model Incorporating Fibroblasts, Macrophages, Endothelial Cells, and Other Immune Cells Such as Innate Lymphoid Cells Enables Animal Model-Independent Rheumatoid Arthritis Research [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/a-long-term-synovial-tissue-3d-model-incorporating-fibroblasts-macrophages-endothelial-cells-and-other-immune-cells-such-as-innate-lymphoid-cells-enables-animal-model-independent-rheumatoid-arthrit/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-long-term-synovial-tissue-3d-model-incorporating-fibroblasts-macrophages-endothelial-cells-and-other-immune-cells-such-as-innate-lymphoid-cells-enables-animal-model-independent-rheumatoid-arthrit/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology